Dr. Gabriel O Te, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 11 Leech Rd, Greenville, PA 16125 Phone: 724-588-2772 Fax: 724-588-4017 |
News Archive
Blood cells have limited lifespans, which means that they must be continually replaced by calling up reserves, and turning these into the blood cell types needed by the body.
Global Fund Will Make 'Every Possible Effort' To Raise Additional Resources: Although pledges to the Global Fund to Fight AIDS, Tuberculosis and Malaria at its recent replenishment meeting did not meet "the lowest estimate of demand," the Fund "will make every possible effort to raise the additional resources that we expect countries to request in the years ahead" through new donor recruitment and "innovative financing approaches," writes Executive Director Michael Kazatchkine in a Lancet comment
As the post-Christmas January blues take hold, young people are risking damage to their health and appearance by using sunbeds on the recommendation of friends and family, according to a new survey by Cancer Research UK.
Pharmasset, Inc. today announces the initiation of a 28-day Phase 2a study with PSI-7977, a chirally pure isomer form of PSI-7851, a nucleotide analog polymerase inhibitor in development for the treatment of chronic hepatitis C (HCV). The trial will evaluate various doses of PSI-7977 in combination with Pegasys (peginterferon alfa 2a) and Copegus (ribavirin) in patients with HCV genotype 1 who have not been treated previously.
Calibr, the drug discovery and development division of Scripps Research, today announced that the U.S. Food and Drug Administration has given clearance to the Investigational New Drug (IND) application for Calibr's "switchable" CAR-T cell therapy, which is being evaluated for the treatment of certain cancers, including relapsed/refractory B-cell malignancies such as non-Hodgkin lymphoma and chronic lymphocytic leukemia.
› Verified 9 days ago